June 30, 2023
admin
Vilin Bio Med IPO Particulars & Guidance at Chanakyanipothi.com,
the Oldest & the most Trusted Investment Website in India for coming up IPOs. Operational since 8th December 1999, this is the Only Investment Platform in India, which has successfully completed 23 Years.
Vilin Bio Med IPO Listing
Listed at Rs. 30
Vilin Bio Med IPO Review:
The company is into Pharmaceutical manufacturing. The profits of past 3 years are not impressive and compared to those figures, the shares are offered at very high valuations. Not much fancy seen in the grey market for this IPO. May avoid.
What is the GMP of Vilin Bio Med IPO?
GMP prior to listing
GMP: Rs. –
Kostak/Fix Rs.0
Subject to Rates: Rs.-
Vilin Bio Med IPO Subscription Status
On 21 June 2023 @ 4.00 (Day 4) (Closed)
NII: 1896000 Shares 01.28T
RII: 1896000 Shares 04.24 T
Total: 3792000 Shares 02.76 T
Vilin Bio Med IPO Particulars & Guidance:
About the business
The Company is engaged in domestic business of manufacturing Pharmaceuticals products and the Manufacturing Unit is located in Roorkee, in the State of Uttarakhand. In order to maintain its competitiveness and to further the cause of Healthcare, the Company has laid a R&D Foundation and state of the art Manufacturing Facility in Roorkee. Its Sales Strategy is to sell its products in bulk to Pharmaceuticals Manufacturers, Marketers and Traders, who in turn provide the channel for sales to customers. Its products are primarily used by other pharmaceutical companies and traders, who ultimately will market it to the distributors and retail customers. It does not sell its products under any brand name. Following are its major products (manufacturing dosage forms):
1 Oral Liquid (Syrups/Suspensions/Dry Powders (beta & Non beta-Lactam)
2Tablets & Capsules (beta & Non beta-Lactam)
3. External Preparations
Get more information about the company @ http://www.vilinbiomed.co.in/
| Vilin Bio Med IPO Details | |
| IPO opens on Tentative | 16 June 2023 |
| IPO closes on | 21 June 2023 |
| Issue Type | Book Built Issue IPO |
| Issue Size | 4000000 Sh /Rs 12 Cr |
| * Fresh Issue | 4000000 Sh /Rs 12 Cr |
| * Offer for Sale | – Sh /Rs – Cr |
| Face Value per share: | Rs. 10 |
| Price Band | Rs.30 |
| Employee discount | Rs. 0 per share |
| Retail Lot Size | 4000 Shares |
| Listing will at | NSE SME |
| Shares offered to | ||
| Shares | Rs. (Cr) | |
| QIB (0%) | – | – |
| NII (50%) | 1896000 | 5.69 |
| RII (50%) | 1896000 | 5.69 |
| Total Shares | 3792000 | 11.38 |
| Retail portion will be oversubscribed by | 474 | |
| Forms | ||
| How much Shares to Apply in Vilin Bio Med IPO? | ||
| Min Retail Application | 4000 Sh | Rs. 120000 |
| Min HNI Application | 8000 Sh | Rs.240000 |
Who are the Promoters of Vilin Bio Med IPO?
VISWA PRASAD SADHANALA, SADHANALA VENKATA RAO, D. SRINIVASA REDDY AND RAMESH REDDY
SAMA
What are the Objects of Vilin Bio Med IPO?
The Company proposes to utilize the Net Proceeds from the Issue
for augmenting additional working capital requirements
| IPO Tentative timetable | |
| IPO opens on | 16 June 2023 |
| IPO Closes on | 21 June 2023 |
| IPO Allotment on | 26 June 2023 |
| Unblocking of ASBA | 27 June 2023 |
| Credit of Shares | 29 June 2023 |
| Listing on | 30 June 2023 |
| Registered Office of the Company Sy.No.115/GF/J, Hanumanji Colony, Brig Sayeed Road, Bowempally, Secunderabad – 500003, Telangana, India |
| Who are the Lead Managers of Vilin Bio Med IPO? |
| Inventure Merchant Banker Services Pvt Ltd |
| Who is the Registrar to IPO? |
| Bigshare Services Pvt. Ltd |
| IPO Financial & Analytical Ratios | ||||
| Year | Total Income | Net Profit | EPS | RoNW |
| Rs.in Cr | Rs.in Cr | Rs. | % | |
| 2019-20 | 16.82 | 0.16 | 0.20 | 2.24 |
| 2020-21 | 11.72 | 0.12 | 0.15 | 1.65 |
| 2021-22 | 11.22 | 0.03 | 0.04 | 0.45 |
| Book Value of the Share on | 31.03.2022 | Rs.8.96 | ||
| Book Value of the Share | after the IPO | Rs.16.28 | ||
| Offer Price | Rs. 30 | |||
| Vilin Bio Med Key Performance indicators |
|
| Upper Price/last EPS | 294.82 |
| Upper price/BV Ratio | 3.35 |
| Upper price/BV after IPO | – |
–
IPO Particulars & Guidance
Peer Comparison:
| As on date of DRHP | FV | Total | PE |
| Rs. | Income (cr) | Ratio of | |
| The IPO Company | 10 | 11.22 | 294.82 |
| JFL Lifescience | 10 | – | 8.65 |
| Vaishali Pharma | 10 | – | 38.25 |
| Anuh Pharma | 5 | – | 13.02 |
# This is only coverage of News related to Grey Market Premium & subject to rates. We do not deal in grey market premium. We do not recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
>>Go to Mainboard IPOs Section: Click
>>Get Good Staff or Job, Click: Staffavailable.com
>>Interested in Used Automobiles or vintage cars? Click: BigGaddi.com
>>Get solid Guidance on Mutual fund Investments, Click: ChanakyaMFGuidance.com
>>Study Stock Research Reports, Click: AnalysisLibrary.com
>>Interested in Crossword Puzzles? Click: Magajmari.com
